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Review
Evaluation of metrics for 
benchmarking antimicrobial use in the 
UK dairy industry
Harriet L Mills,1,2 Andrea Turner,1 Lisa Morgans,1 Jonathan Massey,1 Hannah Schubert,1 Gwen Rees,1 
David Barrett,1 Andrew Dowsey,1 Kristen K Reyher1
The issue of antimicrobial resistance is of global concern across human and animal health. In 2016, the UK 
government committed to new targets for reducing antimicrobial use (AMU) in livestock. Although a number of 
metrics for quantifying AMU are defined in the literature, all give slightly different interpretations. This paper 
evaluates a selection of metrics for AMU in the dairy industry: total mg, total mg/kg, daily dose and daily course 
metrics. Although the focus is on their application to the dairy industry, the metrics and issues discussed are 
relevant across livestock sectors. In order to be used widely, a metric should be understandable and relevant 
to the veterinarians and farmers who are prescribing and using antimicrobials. This means that clear methods, 
assumptions (and possible biases), standardised values and exceptions should be published for all metrics. Par-
ticularly relevant are assumptions around the number and weight of cattle at risk of treatment and definitions of 
dose rates and course lengths; incorrect assumptions can mean metrics over-represent or under-represent AMU. 
The authors recommend that the UK dairy industry work towards the UK-specific metrics using the UK-specific 
medicine dose and course regimens as well as cattle weights in order to monitor trends nationally.
Introduction
Antimicrobial resistance (AMR) is a matter of global 
concern across the human health, animal health and 
agricultural sectors. In May 2015, the World Health 
Organization (WHO) published a global action plan 
to tackle AMR.1 which identified the need for strong 
collaborations between the three sectors to address 
the problem. WHO also publish and maintain a list of 
antimicrobials (AMs), which are of critical importance 
to human health.2 This list of critically important anti-
microbials (CIAs) has been further refined by WHO to 
give a list of highest priority CIAs (HP-CIAs).3 The Euro-
pean Medicines Agency  (EMA) then classified these 
HP-CIAs into two categories: ‘those where the risk to 
public health is estimated as low or limited’ (category 1 
includes macrolides) and ‘those where the risk to public 
health is estimated as higher’ (category 2  includes 
fluoroquinolones, third-  and fourth-generation ceph-
alosporins and colistin) and these have been adopted 
by the UK.4–6 Globally, it is recognised that the use of 
HP-CIAs across sectors needs to be reduced, and the 
EMA has called for significant restrictions in their use 
in animals.7 
In 2014, the UK government commissioned a review 
to analyse the problem of AMR globally and propose 
solutions. This review8 (published mid-2016) specifi-
cally called for a reduction in the use of AMs in farm-
ing and an increase in the regulatory oversight of an-
timicrobial use (AMU) and resistance in animals. The 
UK government response (published September 2016) 
committed to decreasing overall average AMU in live-
stock to 50 mg/kg by 2018, a 19 per cent reduction from 
62 mg/kg in 2014.9 This 50 mg/kg target is for the live-
stock industry as a whole. AMU, however, varies con-
siderably across livestock sectors and therefore the gov-
ernment has also committed to working with individual 
sectors to set appropriate sector-specific reduction tar-
gets by 2017. These targets will focus on encouraging 
best practice and responsible use of antimicrobials, as 
well as safeguarding animal health and welfare.
There has been a concerted effort in the livestock 
industry to raise awareness of AMU, with some food 
retailers and milk buyers placing emphasis on regular 
reporting of usage data. A variety of metrics (measures) 
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for AMU are used across the industry and have been pre-
sented and used in the literature.6 10–18 All of these seek 
to monitor changes in AMU over time, assess the impact 
of policy change, and, potentially, benchmark farms 
or veterinarians against one another. However, each 
metric comes with its own assumptions, meaning that 
each gives a slightly different interpretation and view 
of AMU. In the opinion of these authors, an ideal met-
ric needs to be easily comparable across different units 
(farms, veterinarians, regions), and take into account 
the number and range of animals (ages, breeds, etc) 
to which AMs are being prescribed. In order to be used 
widely in the livestock industries, such a metric should 
also be understandable and relevant to veterinarians 
and farmers who are prescribing and using AMs. Clear 
methods, assumptions (and possible biases), standard-
ised values and exceptions should be published for all 
metrics such that each may be independently calculat-
ed and compared, and the over-riding goal of reducing 
AMR should be kept in mind at all times.
The aim of this manuscript is to specifically focus on 
the pros and cons of a selection of metrics for measuring 
AMU in the UK dairy cattle industry, although most met-
rics presented can be applied to other types of livestock.
Metrics
Five metrics for AMU are described in the following 
section and presented in a summary table at the end of 
the section (Table 5).
Total mg
Total mg of active substance is simple to calculate and 
easy to understand. However, it ignores variation in dose 
rates across AMs and individual differences between 
farms and veterinarians. For example, one farm may 
compare favourably to another only because of dose 
rate differences in the medicines they use; impor-
tantly, this is especially true for the HP-CIAs, which 
tend to have low dose rates (Table 1). Total mg is also 
not suitable for comparison across farms with different 
numbers of cattle: farms using the same amount of a 
particular medicine per animal will have different total 
mg depending on the number of cattle on each opera-
tion. On farms with smaller or lighter animals, total mg 
will be lower even if the number of doses per animal is 
the same as a farm with larger or heavier animals. For 
cattle, AMs (such as lincomycin and tylosin) are some-
times used in footbaths in a way that does not follow the 
clinical recommendations on the summary of product 
characteristics (SPC), under the Cascade system.19 This 
use could be at such quantities that the increase in total 
mg for active substances in those AMs would be heavily 
inflated compared with farms not using AM footbaths—
this applies to all AMU metrics.
Total mg/kg
Total mg/kg6 improves on total mg by dividing the mass 
of the medicines by the total weight of cattle at risk of 
treatment, therefore accounting for variation in cattle 
numbers and weights across farms. However, as with 
total mg, use of this metric may encourage favouring 
of the HP-CIAs for their lower mg per dose (Table  1). 
O’Neill’s review on AMR recommended a reduction in 
the use of the HP-CIAs, although they did not specif-
ically suggest a separate target.8 In order to prevent a 
shift towards the use of HP-CIAs to meet an overall mg/
kg figure, there should always be a separate calculation 
for HP-CIAs (as is shown in the UK VARSS reports6). The 
O'Neill review was primarily motivated by concerns to 
human health; however, the use of HP-CIAs in livestock 
can increase resistance towards medicines that are of 
last resort in human health, increasing the chance of 
limiting effective medicines for humans. In the drive to 
reduce AMR, it is therefore necessary to recognise that, 
in some instances, using more mg of medicine in live-
stock (moving from the use of fluoroquinolones—clas-
sified as HP-CIAs—to tetracyclines, for instance) may 
actually be beneficial.
Commonly, actual cattle weights on farms are not 
known and so most systems rely on estimated weights. 
The published literature presents a large range of cat-
tle weights, for example, weights used for adult milk-
ing cattle range from 425 kg (estimated mean weight 
at time of treatment defined by the European Surveil-
lance of Veterinary Consumption (ESVAC) group20 : if 
this weight is used, the metric is commonly referred to 
as mg/PCU (population correction unit18), 600 kg (used 
by the  Netherlands and Denmark for national report-
ing12 14) to 680 kg.21 Cattle weight also varies by age 
and breed, with the additional complication that many 
herds are of mixed breeds, making the use of a standard 
weight potentially problematic. Additionally, many AMs 
TABLE 1: Demonstrating the different total mg and total mg/kg between two (hypothetical) farms with the same total kg of treated animals who are using 
AMs with different dose rates
Farm Medicine AM type Dose rate (mg/kg) Concentration (mg/ml)
Total weight of treated 
animals (kg)
AMU
Total mg Total mg/kg
1 Ceftiofur (Naxcel, Zoetis, UK) Third-generation 
cephalosporin
6.6 200 60 000 3 96 000 6.6
2 Oxytetracycline (Terramycin LA, 
Zoetis, UK—long-acting dose)
Tetracycline 20 200 60 000 1 200 000 20
Farm 1 is using a third-generation cephalosporin (an HP-CIA), but, as the dose rate of cephalosporins is lower than that of tetracyclines, the total mg of medicine used on farm 1 is less than on farm 2, 
so both metrics appear to be lower for farm 1 than farm 2. The metrics ignore the fact that farm 1 is using an HP-CIA, which is arguably more important to reduce than just minimising total use when 
considering selection for antimicrobial resistance
AM, antimicrobial; AMU, antimicrobial use; HP-CIA, highest priority critically important antimicrobial.
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are specifically (or predominantly) used in youngstock, 
dairy or beef cattle and there is variation in disease 
susceptibility between breeds.22 23 If an average cattle 
weight is known for the farm (through systems such as 
robotic milking machines that have a weigh floor), or if 
an average weight for the farm’s most common breed is 
used, and/or use is divided by age, metrics will give a 
more accurate result for the farm. Data to inform cur-
rent mean weights of the UK cattle for different breeds 
have been collected and these up-to-date estimates will 
help improve accuracy in the UK metrics (H. Schubert, 
S. Wood, K.K. Reyher, H.L. Mills, in preparation).
Using an inaccurate weight for the animals at risk 
of treatment on a farm may result in any of the ‘per kg’ 
metrics under-representing or over-representing actual 
AM use, thereby rendering comparisons across farms 
with different mean weights (eg, due to different breeds) 
inaccurate (Table 2).
‘Per kg’ metrics are also subject to further inaccu-
racies and lack of comparability between users if the 
total kgs of animal at risk of treatment take different 
animal populations into account. For example, if only 
adult milking cattle are included when calculating to-
tal kgs, a dairy farm that rears its own youngstock will 
have the same kg weight assigned as an equivalent farm 
that does not rear youngstock, even though there are 
more animals at risk of treatment with AMs (Table 3). 
Similarly, if all animals on the holding are included, a 
dairy farm keeping beef animals is likely to have a lower 
mg/kg when compared with a dairy-only farm with the 
same number of animals, due to the relatively low use of 
AMs in beef animals when compared with dairy.
An alternative to mg/kg would use production data 
instead of weight, such as mg/1000 L of milk produced. 
These sorts of metrics might be valued by some farm-
ers. There have, however, been suggestions that metrics 
taking into account production data imply to the public 
that AMs are present in animal products at substantial 
levels, which is misleading to consumers.
Daily dose metrics
Defined daily dose (DDD) metrics divide the total mg of 
medicine used by both total animal weight and an esti-
mate of the daily dose for that medicine. These metrics 
are commonly used in human medicine24 and help 
to overcome the issue of total mg and mg/kg metrics 
not accounting for different dose rates in AMs (high-
lighted in Table  1). As well as using either actual or 
standard weights for animals at risk of treatment (see 
mg/kg), daily dose metrics can use ‘actual’ daily doses 
(eg, farm-specific) or ‘defined’ daily doses (eg, recom-
mended or standard doses; Fig 1).
The ESVAC group have formalised a defined daily 
dose for animals (DDDvet) metric for dairy cattle, which 
uses fixed daily dose definitions and a standard weight 
of 425 kg (estimated mean weight at time of treatment 
for dairy cattle).11 Daily doses for DDDvet are defined per 
active substance and administration route rather than 
per-individual product, and are based on the arithme-
tic mean dose of all veterinary medicine products, giv-
en by the standard product documentation from nine 
countries: Czech Republic, Denmark, Finland, France, 
Germany, the Netherlands, Spain, Sweden and the UK. 
Because these definitions represent an average across 
countries and do not take into account within-product 
variation they may not reflect actual prescription and 
TABLE 2: Demonstrating the problem of farm-specific cattle weights vs 
standard weights when comparing antimicrobial use (AMU) in total mg/kg 
across (hypothetical) farms
Farm Total mg
Total number of 
adult milking 
cattle
Mean cattle 
weight (kg)
AMU
Total mg/kg using 
mean cattle weight 
specific for that 
farm
Total mg/kg using 
ESVAC 425 kg mean 
weight at time of 
treatment
3 1 000 000 100 750 13.3 23.5
4 1 000 000 100 450 22.2 23.5
Both farms have the same number of cattle and use the same total mg of medicine, but cattle on 
farm 3 are heavier than those on farm 4 (eg, Holstein-Friesian vs Jersey). Total mg/kg using a cattle 
weight specific to that farm gives more accurate figures than using a standard weight (in this case, 
the standard weight chosen is 425 kg, the estimated mean weight at time of treatment for dairy cattle 
defined by the European Surveillance of Veterinary Consumption group (ESVAC))
TABLE 3: Demonstrating how the animal population included in the total kgs treated calculation can influence the final value for total mg/kg
Farm Total mg
Total number of 
adult milking 
cattle
Total weight of adult milking 
cattle using 600 kg standard 
weight (kg)
Total number of 
youngstock <12 months
Total weight youngstock 
<12 months using 100 kg 
standard weight (kg)
Antimicrobial use
Total mg/kg (including only adult 
milking cattle weight)
Total mg/kg (including both adult 
milking cattle and youngstock weight)
5 1 000 000 100 60 000 0 0 16.7 16.7
6 1 000 000 100 60 000 50 5000 16.7 15.4
Here, both (hypothetical) farms have the same number of adult cattle, but farm 5 does not have youngstock; if only adult cattle are included in total kg then the total mg/kg are the same for both farms. If both adults and youngstock 
are included then total mg/kg is lower for farm 6 (which does have youngstock)
Parameters
to be defined
Defined doses
or
defined courses
Cattle weight 425 kg
Increasing amount of specific information required
UK
average
Age
specific
Breed
specific
Farm
specific
DDD or DCD
metrics
ESVAC Country Unit
FIG 1: Flow chart explaining the different options for defined daily dose 
(DDD) and defined course dose (DCD) metrics. These metrics can (and have) 
been defined at European Surveillance of Veterinary Consumption (ESVAC) 
group, country or unit level, requiring doses or courses to be defined or 
known specifically for that level. These metrics also require cattle weights, 
and the ESVAC, country or unit level may define weight in different ways. 
The amount of specific information required increases from left to right in 
the figure as metrics become more representative of the actual situation 
on farms, with a trade-off of increasingly granular information necessary to 
calculate the metrics.
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use practices in an individual country, meaning DDDvet 
may be less representative at a country, farm or veteri-
nary practice level.
Daily dose definitions have been published for all 
products except long-acting gamithromycin and tildip-
irosin (which will be published at a later date).11 For 
dairy cattle specifically, there is a problem accounting 
for use of intramammary tubes. These have low mg per 
dose (and therefore do not substantially increase mg/
kg), but do impact the number of daily doses adminis-
tered. Currently, dry cow antibiotic tubes have not been 
assigned a DDDvet value, although lactating cow tubes 
have (1/teat).11 Another issue for cattle is the inclusion 
of AMs used under the Cascade in footbaths—because 
there are no defined doses for this method, this use can-
not be included in daily dose metrics. However, AMs 
can be used at very high quantities in footbaths, mean-
ing that excluding them can under-represent actual 
AMU on farms.
To improve representativeness, daily dose metrics can 
be defined at country level (ie, the fixed daily dose defi-
nitions and standardised weights would be specific to 
that country) or at the unit level (eg, farms or veterinary 
practices, by using the individualised dose regimens and 
even weights actually reported by the farm or veterinary 
practice; Fig 1). These versions are potentially powerful, 
as the inclusion of more accurate data improves the repre-
sentativeness of the metric and allows better comparisons 
across countries or units.16
Whether the minimum, mean or maximum rec-
ommended rates are chosen as the defined dose rate 
significantly impacts the final DDD metric, illustrat-
ing how different choices—even taken within the rec-
ommended range—could alter the interpretation of 
AMU (Table  4). These biases also apply if the actual 
dose rate used on the farm is different to the defined 
dose rate, for example, the maximum dose rate may 
often be administered on farms so the mean may not 
accurately reflect use. The choice of animal weight 
can also cause similar biases, as previously discussed 
(Table 2).
Note that for different countries and AMU monitor-
ing systems, daily dose metrics have also been termed 
animal daily dose (ADD), defined animal daily dose 
(DADD) and defined daily dose animal (DDDA). Calcula-
tions are the same, but different countries and systems 
use different daily doses and cattle weights, and include 
different specific (eg, age) groups.
Course dose metrics
Course dose metrics attempt to assign the number of 
courses an animal receives, taking into account the 
daily dose and the course length. The ESVAC group have 
formalised a defined course dose for animals (DCDvet)11 
as a suitable metric for monitoring across the EU. DCDvet 
is similar to DDDvet, but uses fixed course dose defini-
tions instead of fixed daily dose definitions (based on 
the same nine European countries as DDDvet) as well 
as an assumed weight of 425 kg. These assumptions 
introduce the same problems as for DDDvet discussed 
above. Unlike DDDvet, however, both intramammary 
lactating and dry cow tubes have DCDvet values: 3/teat 
for lactating cow tubes and 4/udder for dry cow tubes.11
As with daily dose metrics, if actual dosage regi-
mens, course lengths and cattle weights are used, these 
would produce the most accurate DCD metric for each 
unit (Fig 1). However, this level of detail is not always 
available.
Cow calculated course
Cow calculated course (CCC) is a metric conceived in 
the UK as part of an XLVet initiative (T. Clarke, personal 
communication). This metric uses course length data 
and dosing regimen as per the UK SPC documents 
and the number of cattle on the holding (taken from 
the Cattle Tracing System, which uses British Cattle 
Movement Systems (BCMS) data). CCC splits out medi-
cine use into youngstock and adult stock by assuming 
certain products are only used in certain age groups. 
Udder preparations and short-acting injectable antibi-
otics are allocated to adults, and long-acting injectable 
and oral antibiotic products are deemed as youngstock 
treatments. CCC tallies the courses of each medicine 
used in a set time period and divides this by the number 
of animals on the holding. CCC makes assumptions on 
cattle weight (100 kg for youngstock (<24 months) and 
600 kg for adult dairy animals (>24 months)) in order 
to work out how many courses are in a given saleable 
unit of medicine. When the course length is a range of 
days on the SPC, CCC uses the longest course length 
and the highest dose rate as assumptions for calcu-
lating how many courses one saleable unit of medicine 
contains. To make the metric more accurate at a farm 
level, the actual course length per medicine as given 
by the farmer and ideally the on-farm cattle weights 
and dose rates per medicine could be used (Figs 1,2). 
Although these parameters should be derivable from 
TABLE 4: Demonstrating the impact different dose rates may have on the final defined daily dose (DDD) metric
Medicine Dose rate (mg/kg) Total number of adult milking cattle
Total weight of adult milking cattle using
600 kg standard weight (kg)
Antimicrobial use
Total mg Total mg/kg DDD
Tylosin 4 (minimum) 100 60 000 1 00 000 1.67 0.42
Tylosin 7 (mean) 100 60 000 1 00 000 1.67 0.24
Tylosin 10 (maximum) 100 60 000 1 00 000 1.67 0.17
This table uses tylosin as an example, showing the difference in DDD when taking the minimum, mean or maximum recommended dose rate.30 Tylosin has a range of dose rates, resulting in a range of DDD values.
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on-farm records, this level of detail may not be easy to 
collect.
Comparison of metrics using real data
In order to further illustrate the different metrics 
described above and in Table 5, data on AM use for a 
12-month period during 2015–2016 from six farms 
were collated (Figure 2). These six farms were selected 
from a wider project to represent specific segments of 
the industry: farms A and B are high-yielding, indoor 
Holstein-Friesian herds; farms C and D are extensive 
grazing, block-calving, crossbred herds; farms E and F 
are average-sized, average production Holstein-Friesian 
herds. Farms ranged in size from 90 to 500 cows and all 
but farm A reared calves (<12 months of age) on site (so 
medicine use included use in calves for all but this farm). 
Farm medicine reviews were compiled from veterinary 
sales data supplemented with on-farm records with 
the exception of farm A, which used on-farm medicine 
records only, further details of the management prac-
tices and data collection on these farms can be found in 
online supplementary material S1 and table S1.
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FIG 2: Antimicrobial use for six farms over a 12-month period illustrated as total mg/kg, defined  daily  dose for animals as defined by the European 
Surveillance of Veterinary Consumption (ESVAC) group (DDDvet), as suggesetd for the UK (DDDUK) and on an individual farm level (DDDfarm), defined course 
dose (DCD) as defined by ESVAC (DCDvet), as suggested for the UK (DCDUK) and on an individual farm level (DCDfarm). Figures on the left show total use with 
the darker shading indicating the highest priority critically important antimicrobials (HP-CIAs3–5); figures on the right show HP-CIA use exclusively. Farms are 
coloured differently and plotted in order of their use for each metric.
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The AM use of these farms is represented by total 
mg/kg, DDDvet, DDDUK, DDDfarm, DCDvet, DCDUK 
and DCDfarm metrics. DDDvet and DCDvet were calcu-
lated using the ESVAC-defined weight of 425 kg using 
only adult stock numbers. DDDUK and DCDUK use dose 
rates and course lengths specific to the UK, obtained 
from SPCs and weights of 600 kg using only adult 
stock numbers. DDDfarm and DCDfarm use dose rates 
and course lengths specific to the farm and weights of 
600 kg for adults and 100 kg for calves under 12 months 
of age (because for DDDfarm and DCDfarm, antimicro-
bials can be assigned to adults or calves). Total mg/kg 
also assigns antimicrobial use to adults or calves, with 
the same weights as DDDfarm.
A number of medicines were excluded across all 
metrics to allow comparability of benchmarking (eg, 
where DDD values were not defined). Further details of 
the assumptions made are given in online supplemen-
tary material S2 and figures S1,S2 show the sensitivity 
of the metrics to these exclusions.
The illustrative metrics are presented for total AMs 
and for the HP-CIAs (third-generation and fourth-gener-
ation cephalosporins and fluoroquinolones) separately. 
In each panel, farms are ranked according to their use 
by that metric. It is interesting to note that the ranking is 
not the same across all metrics for total AM use (figures 
on the left), although it is largely the same for HP-CIA 
use (figures on the right).
Some interesting points are illustrated by these pan-
els. For instance:
 ► Farm A is ranked last when using ESVAC or the UK-level dose 
or course metrics for total use (DDDvet, DDDUK, DCDvet and 
DCDUK) but, using mg/kg and farm-specific metrics (DDDfarm 
and DCDfarm), it falls in the middle. This variation is primarily 
due to use of intramammary tubes with double daily doses and 
longer course lengths (beyond recommendations) under the 
Cascade. This increases dose and course metrics that assume 
standard doses have been given, but, given the relatively low 
amount of active ingredient in intramammary tubes, does not 
significantly increase mg/kg. However, farm A uses no HP-CIAs.
 ► Farm B and F swap rank when comparing DDDvet with 
DDDUK, and DCDvet with DCDUK for total use, indicating 
the difference between ESVAC and the UK-level metrics.
 ► Farm C and D (extensive, block-calving, crossbred herds) 
are consistently low users across all metrics for total use, al-
though farm C uses more HP-CIAs.
 ► Farm E is ranked last when using farm-specific metrics for 
total use (DDDfarm and DCDfarm), but has a better position 
for ESVAC and the UK course and dose-level metrics. This is 
because much of the injectable medicine used on this farm is 
used in calves and mg/kg, DDDfarm and DCDfarm split med-
icine use into adults and calves. These differences illustrate 
the point that more specific dosage and weight information 
can offer further insight into AMU on cattle farms, although 
this comes with the trade-off that more effort is required to 
gather more farm-specific data.
 ► Farm F is always benchmarked as the largest user of HP-CIAs 
but is never ranked as the largest in total use.
Current use of metrics
Each metric presented in this manuscript is in common 
use. For example, in the UK, daily dose metrics are used T
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by at least two retailers and CCC is currently in use by 
veterinary practices and retailers. Total mg/PCU is used 
to analyse the UK-level sales data from pharmaceutical 
companies.18 DDDvet and DCDvet have been used in 
Ireland.13 Country-specific daily dose metrics are used 
in AMU reporting systems in the Netherlands14 and 
in Denmark (via VetStat,12 Danish Integrated Antimi-
crobial Resistance Monitoring and Research Program 
(DANMAP) and the Danish Veterinary and Food Admin-
istration (DVFA)). Interestingly, DANMAP and the DVFA 
use different defined doses resulting in significant 
discrepancies in measurements of AM consumption 
using data from the same country.10 Daily dose metrics 
have also been used in studies outside of Europe (eg, 
Canada17 and Argentina15). Australia have published 
their overall AM figures as mg/PCU.25
Current work at the University of Bristol with the UK-
based farmers, veterinarians and retailers as well as 
the experience in the Netherlands26 suggests the need 
for specific metrics to be chosen and used consistently. 
These metrics need to be clearly explained so that us-
ers understand what data are required and the assump-
tions and biases behind the calculations. For a metric to 
be useful to farmers and veterinarians, it must be good 
for benchmarking purposes (ie, it must be accurate and 
comparable at the unit level). This ideally means a met-
ric that takes into account varying cattle numbers and 
weights as well as different management systems and 
does not penalise farmers or veterinarians for using 
medicines with higher mg/kg dose rates, such as the 
first-line AMs.
Data issues and requirements
All metrics require accurate, representative and vali-
dated data and parameterisation in order to be useful. 
The section below discusses issues with obtaining 
detailed data and medicine information, and the 
assumptions and sensitivities around these data.
Data collection and data quality
Data for assessing AMU may come from the farmer 
or veterinarian (the actual usage amounts, cattle 
numbers and ages, average cattle weights, actual 
dosing and course regimens) and from regulatory 
bodies such as the EMA, Veterinary Medicines Direc-
torate (VMD) or National Office of Animal Health 
(NOAH) (advised/defined dosing and course regimens 
for each medicine, mg of active substance per medi-
cine unit). Cattle numbers may also be obtained from 
the BCMS in Great Britain and the Animal and Public 
Health Information System in Northern Ireland, which 
give information on all individual cattle on farms 
at any one time (NB as the reporting process is not 
perfect, these data are not always 100 per cent accu-
rate). Herd size can increase and decrease over an 
analysis period, which may cause inaccuracies in the 
metric calculations if, for example, animal numbers 
are taken from one timepoint rather than using an 
average over the period.
While all farmers must keep records of medicine use 
in a medicine book,27 animal health and welfare tasks 
are likely to be prioritised instead, which can make re-
cord keeping a rushed exercise and lead to low-quality 
data.28 Automating data entry on farms, with medicine 
recording linked to a standard identifier (eg, VM num-
ber), could improve data quality. For example, teams 
such as VirtualVet (www. virtualvet. eu/) aim to develop 
systems allowing farmers to scan the bottle or pack of 
medicine, scan the eartag of the cattle being treated and 
add dose information. However, farm-side automation 
requires a robust system and hardware that is function-
al on farm as well as a concerted effort from farmers 
to use it. Automation on the side of the veterinarian is 
more straightforward as many veterinary practices al-
ready use practice management systems to enter sales 
data, and information can be extracted from these (as 
shown by VetIMPRESS, FarmVet Systems, www. vetim-
press. com/), although this often requires substantial 
cleaning. However, the use of sales data assumes that 
all medicines sold to the farmer are used on that par-
ticular farm, for the animals specified, within the spec-
ified time period and at the correct dose rate, etc.29 In 
fact, veterinarians anecdotally report that farmers may 
treat animals using unused medicines from previous 
sales; in these instances, it may be that the actual dose 
regimen does not match the recommended regimen for 
the medicine.
Some countries have strict monitoring systems for 
medicine sales in place, and similar methods could be 
implemented in the UK. The Netherlands, for example, 
requires veterinarians to upload sales data to ‘Medir-
und’ within 14 days of the sale (www. medirund. nl/ di-
erenarts/); this system then produces quarterly reports 
of AMU (using daily dose metrics) for both the veteri-
narian and the farmer.
Assumptions and sensitivities
In the absence of individualised weight data, the weight 
assumption used in calculations must be clearly stated 
and the sensitivity of the metrics to this assumption 
should be explored, particularly for comparison across 
farms or veterinarians. Similarly, assumptions and 
sensitivities about the treated population size, age and 
breed should be clearly presented in analyses.
If a metric is calculated for AM use over only a num-
ber of months (eg, quarterly), there may be seasonal 
trends due to farm management (eg, calving) that may 
skew the data; if instead a metric uses data from an en-
tire year, these variations may be mitigated (although 
in some cases there may still be outliers). With all met-
rics, it is preferable to continually measure and monitor 
over time: more regular monitoring will provide more 
detailed information, aiding in understanding of the 
system and changes over time.
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Medicine information
Every medicine licensed in animals in the UK has 
an SPC document which includes text summaries of 
recommended dose rates and course length for every 
animal in which that medicine is licensed for use, 
along with the active substances the medicine contains 
and their concentrations. In order to use these data in 
metric calculations, the values must be extracted from 
the text into an accessible format. Additionally, many 
SPCs present a range of doses or course durations, and 
a single value must be chosen, introducing potential 
inaccuracies (table 4).
At present, the EMA and others do not calculate 
DDDvet and DCDvet at the product level, but rather at 
the level of the active substance (ie, oxytetracycline for 
each species and administration route). This means 
that there are currently no set standards for individu-
ally licensed products, and all medicines containing 
a certain active substance for use in a certain species 
will be using a single set dose rate or frequency. Work 
at the University of Bristol has also shown that there are 
some substantial differences in doses from the UK SPCs 
to the doses accepted as part of the ESVAC DDDvet and 
DCDvet calculations. There are a number of medicines 
that have the UK dose rates that are half or sometimes 
double those specified by ESVAC; these occur in the in-
jectable antibiotics as well as oral preparations. To pre-
vent duplication of effort and to standardise decisions 
on dose rates and frequencies appropriate to the UK, 
as well as to allow comparisons across analyses using 
these metrics, these authors recommend that a defini-
tive list of standardised values for each of the licensed 
veterinary medicines in the UK is produced. This could 
be achieved by convening a workshop of key stakehold-
ers to establish the UK figures and including these val-
ues on future iterations of the downloadable Product 
Information Database Snapshot currently available on 
the VMD website ( htt ps:/ /www .vmd .def ra.g ov.uk/ Produ 
ctIn format ionDatabase/). Together with the VMD, the 
authors are currently producing such a list of medicines 
licensed in cattle in the UK to be published and main-
tained as a comprehensive standardised medicines 
database.
Discussion
Many metrics have been presented and not one in itself 
is perfect. It is the assertion of these authors that the 
most elucidating metrics for the UK dairy industry 
would be the UK-specific versions of the daily dose and 
course metrics using actual (or the UK-estimated) cattle 
and youngstock weights along with actual (or defined 
the  UK-specific) treatment-level dose rates and course 
durations for medicines currently licensed in the UK. 
These UK-level metrics for livestock would also need 
clear assumptions for determining the number and 
type (specifically age) of animals at risk of treatment. 
Of course, a ‘gold-standard’ metric would use doses and 
courses specific to the unit (eg, farm or veterinarian) 
and use actual animal number and weight data. This is a 
possible target for the future, as systems to collect farm-
level, individual cattle data are being developed but are 
not currently in wide use (VetIMPRESS, VirtualVet).
If the UK could publish its standard daily doses for 
veterinary medicines in the same way as it does for hu-
man medicine (ie, for every individual product rather 
than by active substance and route as are currently 
provided by ESVAC24), a UK-specific daily dose metric 
would be feasible and would also allow comparison of 
usage with the medical profession on a country-wide 
basis. Part of the required standardisation will be for-
malising the choice of medicines to include in the met-
ric (and, indeed, to include in reduction targets). For 
example, how antibiotic sprays, footbaths and dry cow 
tubes should be included in daily dose metrics, and 
whether HP-CIAs should also be reported separately to 
total use and have additional targets.
Given the work required to tailor dose and course 
metrics for the UK, this may prove infeasible, at least 
in the short-term. As an alternative, the next best op-
tion may be the DDDvet and DCDvet metrics currently 
being standardised by ESVAC.11 Although these metrics 
provide Europe-wide generalisations of dose rates and 
course lengths and have the limitation of defining only 
by active substance, the availability of the standardisa-
tion makes these metrics appealing until such data can 
be generated for the UK.
As an alternative to daily dose metrics, total mg/kg is 
simple to calculate and understand and requires none 
of the standardisation decisions. If presented with the 
relevant caveats and presented separately for HP-CIA 
and non-HP-CIA medicines, mg/kg is suitable for track-
ing usage on a single unit (farm, veterinary practice or 
retailer) over time. However, mg/kg is less suitable for 
cross-unit comparisons (unless farm-specific weights 
are used).
This manuscript seeks to elucidate the pros and cons 
of the current metrics being considered for measuring 
AMU in the UK cattle industries. The ultimate reason for 
use of these metrics should be to aid efforts to reduce 
AMR and to encourage best practice stewardship of 
AMs across the livestock industries. It is recognised that 
encouraging low AMU needs to be balanced against 
maintaining animal health and welfare and that indi-
vidual farm context is important to inform the most re-
sponsible use of AMs on that farm.
In recent years, the move towards routine record-
ing and collection of usage data at farm and veterinary 
practice level has steadily increased, and, although 
there are still questions about the quality of these types 
of data, improvements are being made continually as 
technology and software develop. Availability of relia-
ble data would encourage parties to make use of these 
data to drive change. In the experience of these authors, 
farmers, veterinarians and retailers are all keen to use 
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data to understand and reduce usage of AMs. The UK 
stands to learn much from other countries where such 
practices have already been employed and, with the 
current drive from VMD and others, this is becoming a 
priority.
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